Linog, Aliah P.

HRN: 25-72-27  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
CO-AMOXICLAV 625MG (TAB)
03/20/2026
03/27/2026
PO
625 Mg
BID
S/P NSVD; PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: